Home > Journals > Minerva Biotechnology and Biomolecular Research > Past Issues > Minerva Biotecnologica 2019 September;31(3) > Minerva Biotecnologica 2019 September;31(3):93-9

CURRENT ISSUE
 

JOURNAL TOOLS

eTOC
To subscribe
Submit an article
Recommend to your librarian
 

ARTICLE TOOLS

Publication history
Reprints
Permissions
Cite this article as
Share

 

REVIEW   

Minerva Biotecnologica 2019 September;31(3):93-9

DOI: 10.23736/S1120-4826.19.02556-4

Copyright © 2019 EDIZIONI MINERVA MEDICA

language: English

Dupilumab to target interleukin 4 for inflammatory bowel disease? Hypothesis based on a translational message

Angelo ARMANDI 1, Silvia BONETTO 1 , Rinaldo PELLICANO 2, Gian Paolo CAVIGLIA 1, Marco ASTEGIANO 2, Giorgio M. SARACCO 1, Davide G. RIBALDONE 3


To access the FULL TEXT of this article choose one of the two following options:

PURCHASE THE ARTICLE

You can access the full text of this article (PDF and HTML if available) for 2 days at a price of:  € 45,00.

INDIVIDUAL SUBSCRIBERS/MEMBERS LOGIN


TO SUBSCRIBE

top of page